Follow Important Email Alerts on Stocks like TEVA from SpeculatingStocks.com.
TEVA 'Buy' / 'Sell' Stats
Sentiment Over the Last:
10-Mins: B:0 S:0
1-Hour: B:0 S:0
6-Hours: B:0 S:0
1-Day: B:0 S:0
3-Days: B:0 S:0
1-Week: B:0 S:0
and more... sign up .
More TEVA Social Data
Top Stories Today 1m
Followers: 0
'Buys' : 1
'Sells' : 1
'Buys' 7 AM :
0
'Sells' 7 AM :
0
Teva Pharmaceutical Industries Limited ($TEVA)
$TEVA Teva Pharma beat by $0.12, reported revenue in-line; lowered FY22 EPS in-line, revenue mostly below consensus; announced agreement in principle on terms for nationwide opioids settlement.
$TEVA Teva Pharma beat by $0.12, reported revenue in-line; lowered FY22 EPS in-line, revenue mostly below consensus; announced agreement in principle on terms for nationwide opioids settlement.
$TEVA Teva Pharma has reached an agreement with the City and County of San Francisco and the People of the State of California that settled opioid-related claims asserted on behalf of the County and City of San Francisco.
$TEVA Teva Pharma appointed Eric A. Hughes, MD, PhD as Executive Vice President, Global R&D and Chief Medical Officer; will begin his employment on August 1.
$TEVA Teva Announces Promising Interim Results From Its Study PEARL, About the Impact of AJOVY (fremanezumab).
$TEVA (Teva Pharmaceutical Industries Limited)
has significant institutional ownership of at least 20% with institutional ownership of 46.74%.
$TEVA Teva Pharma reached agreement with Aurobindo resolving AUSTEDO patent dispute.
$TEVA Teva Pharma reached agreement with Aurobindo resolving AUSTEDO patent dispute.
$TEVA Teva Pharma reached agreement to settle opioid-related claims in West Virginia.
$TEVA Teva Presents New Long-Term AUSTEDO (deutetrabenazine) Tablets Data at 2022 American Psychiatric Association Annual Meeting.
$TEVA (Teva Pharmaceutical Industries Limited)
has significant institutional ownership of at least 20% with institutional ownership of 45.35%.
$TEVA Teva Pharma welcomes the UK Medicines & Healthcare Regulatory Agency decision to grant a licence for Ongavia.
$TEVA Teva Announces New Findings Highlighting Potential of ProAir Digihaler (albuterol sulfate) Inhalation Powder to Address Asthma Treatment Challenges.
$TEVA Teva Pharma reported EPS in-line, missed on revenue; reaffirmed FY22 EPS guidance, lowered FY22 revenue guidance.
$TEVA Teva Pharma announced settlement with Lupin to resolve dispute over ANDA for a generic deutetrabenazine product.
$TEVA Teva Pharma and MedinCell receive Complete Response Letter for NDA for TV-46000/mdc-IRM.
$TEVA Teva Pharma and MedinCell receive Complete Response Letter for TV-46000/mdc-IRM from FDA.
Go to Reactions Related to TEVA!
React Anonymously Get a Free Account .
TEVA Sentiment Today (Since 7 AM ET)
Be the Next Pulse User to Follow, 'Buy', or 'Sell' TEVA .
Copy the Widget Code for TEVA
The Revolution in Speculation Continues...
25,776 symbol pages... 1322
users... 3,293,329 pulses... not one
unhappy user. Sign up now, free! Newest SpeculatingStocks Pulse User bluedragond
Headlines for Teva Pharmaceutical Industries Limited (TEVA)
